What is the recommended blood pressure target for adults over 65 years of age, and how should antihypertensive therapy be initiated and titrated?

Blood Pressure Goals for Adults Over 65 Years

For community-dwelling adults over 65 years, the blood pressure target should be systolic <130 mm Hg and diastolic <80 mm Hg, provided the regimen is well tolerated. 1, 2

Target Blood Pressure by Patient Characteristics

Non-Frail, Community-Dwelling Elderly (≥65 years)

• Target: <130/80 mm Hg when treatment is tolerated 1, 2
• The 2025 ACC/AHA guideline explicitly applies the <130/80 mm Hg target to community-dwelling adults aged ≥65 years 1
• This represents a shift from older guidelines that recommended <150 mm Hg for this population 3

Frail or Very Elderly (≥80 years)

• Target: <140/90 mm Hg is appropriate for most frail older adults 4
• Frail elders may require higher thresholds and should be managed with monotherapy and less aggressive goals 4
• Individualize based on frailty status, as guidelines explicitly advise against aggressive lowering in markedly frail patients 4

Initiation and Titration Strategy

First-Line Medication Selection

• Thiazide-type diuretics (hydrochlorothiazide or chlorthalidone), long-acting dihydropyridine calcium channel blockers (amlodipine), or ACE inhibitors/ARBs (enalapril, candesartan) are first-line agents 1, 5
• For isolated systolic hypertension in the elderly, thiazide-type diuretics and calcium channel blockers are specifically recommended 4
• Beta-blockers should be avoided as first-line therapy in patients >60 years due to less stroke prevention benefit and potential worsening of orthostatic symptoms 4

Dosing Approach

• Start with a single first-line agent at low dose for stage 1 hypertension (SBP 130-139 mm Hg and DBP 80-89 mm Hg) 1
• Titrate slowly in elderly patients to mitigate adverse effects that are more common in frail older adults 4
• Sequential addition of other agents as needed to achieve BP control 1
• Target should be achieved within approximately 3 months after initiating or adjusting therapy 2

Critical Safety Considerations

• Avoid diastolic BP <60 mm Hg, especially in patients with coronary artery disease or left ventricular hypertrophy 2
• Maintain diastolic pressure in the range of 70-79 mm Hg 2
• Measure blood pressure in both supine and standing positions to detect orthostatic hypotension, which is common in elderly hypertensive patients 4
• Central α-2 agonists (clonidine, tizanidine) are especially likely to provoke dizziness in older adults and should be avoided 4

Common Pitfalls to Avoid

Medication-Related Errors

• Do not combine ACE inhibitors, ARBs, and/or renin inhibitors due to potential for harm 1
• Avoid aggressive lowering in patients with standing systolic BP <110 mm Hg, as these patients were excluded from major trials like SPRINT 4

Monitoring for Adverse Effects

• Watch for hypotension, syncope, electrolyte disturbances, falls, and acute kidney injury while titrating to target 1, 3
• Low-quality evidence shows increased risk for syncope with treatment to lower BP targets (RR 1.52) 3
• Cough and hypotension are the most frequently reported adverse events with intensive BP lowering 3

Evidence Quality and Guideline Evolution

The 2025 ACC/AHA guideline 1 represents the most current evidence and supersedes the 2017 ACP/AAFP guideline 3 that recommended a more conservative target of <150 mm Hg for adults ≥60 years. The newer guideline is supported by high-quality randomized controlled trials demonstrating that lowering SBP by 10 mm Hg decreases CVD events by approximately 20-30% 5. The key distinction is that the <130/80 mm Hg target applies specifically to community-dwelling, non-frail elderly patients who can tolerate the regimen 2, 4.